Carbachol
Cystic Fibrosis
The Hospital for Sick ChildrenSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 73/ 100
Competitive context
71 Active assets in the Cystic Fibrosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Liprotamase Anthera Pharmaceuticals | Phase 4 | BBB |
Lumacaftor Hospices Civils de Lyon | Phase 4 | BBB |
ELEXACAFTOR Meyer Children's Hospital IRCCS | Phase 4 | BBB |
vx-121 Vertex Pharmaceuticals Incorporated | Phase 3 | BBB |
Colistin Liverpool Heart and Chest Hospital NHS Foundation Trust | Phase 4 | BBB |
View all 50 →
Same molecule, other indications
Carbachol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →